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Wildlife Science
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ABSTRACT. Chronic wasting disease (CWD) is a transmissible spongiform encephalopathy 
(TSE) that affects members of the Cervidae family, including deer (Odocoileus spp.), elk (Cervus 
Canadensis spp.), and moose (Alces alces spp.). While CWD is a neurodegenerative disease, 
lymphoid accumulation of the abnormal isoform of the prion protein (PrPSc) is detectable early in 
the course of infection. It has been shown that a large portion of the PrPSc lymphoid accumulation 
in infected mule deer takes place on the surface of follicular dendritic cells (FDCs). In mice, FDC 
expression of PrPC has been shown to be essential for PrPSc accumulation. FDCs have been shown 
to normally express high levels of PrPC in mice and humans but this has not been examined in 
natural hosts for CWD. We used double immunofluorescent labeling and confocal microscopy to 
determine the PrPC expression characteristics of B and T lymphocytes as well as FDCs in palatine 
tonsils of CWD-negative mule deer and elk. We detected substantial PrPC colocalization with all 
cellular phenotypic markers used in this study, not just with FDC phenotypic markers.
KEY WORDS: chronic wasting disease, confocal microscopy, follicular dendritic cell, palatine tonsil, 
T lymphocyte
Chronic wasting disease (CWD) is a fatal neurodegenerative disease that affects wild, as well as captive cervids including deer 
(Odocoileus spp.), elk (Cervus canadensis spp.), and moose (Alces alces spp.) [2, 42, 43]. Classified as a transmissible spongiform 
encephalopathy (TSE), CWD and other TSEs are commonly referred to as prion diseases to denote the accumulation of an 
abnormal isoform (PrPSc) of the normal cellular prion protein (PrPC) [41]. Both PrPC and PrPSc have the same primary structure 
and differ only in conformation. Details concerning the natural transmission of CWD are unknown, but horizontal transmission and 
oral assimilation of infectious PrPSc are thought to be important in maintaining the disease in wild populations [28].
Early in the course of CWD infection, PrPSc propagates and accumulates in lymphoid tissues prior to neuroinvasion [27]. 
This characteristic early lymphoid accumulation is seen in nearly all cases of CWD-positive mule deer and approximately 80% 
of CWD-positive elk [33, 34, 40]. The degree of early lymphoid involvement varies throughout the TSEs. Scrapie of sheep and 
goats, and variant Creutzfeld-Jakob disease in humans all exhibit PrPSc accumulation within secondary lymphoid tissues while 
there is a lack of appreciable lymphoid accumulation in cattle with bovine spongiform encephalopathy (BSE) [10, 39]. The results 
of a study by Jeffrey et al. [14] suggest that the extent of lymphoid involvement might be related to the species being inoculated 
rather than to the origin of the infectious prions since sheep inoculated with BSE material exhibit lymphoid accumulation of PrPSc. 
In contrast, European red deer (Cervus elaphus elaphus) orally inoculated with infectious BSE material developed disease, but 
did not accumulate PrPSc within lymphoid tissues whereas CWD inoculated animals of the same species exhibited intense PrPSc 
immunohistochemical (IHC) staining in rectal lymphoid tissue and retropharyngeal lymph node [24].
Mule deer and elk with CWD display lymphoid PrPSc accumulation that is focused on the germinal center within lymphoid 
follicles [34, 36]. Within the germinal centers of CWD-positive mule deer, the surfaces of follicular dendritic cells (FDCs) and B 
lymphocytes have been shown to accumulate the majority of the lymphoid PrPSc [32]. The accumulation of PrPSc on the surface of 
FDCs is not unique to CWD in mule deer. Both sheep and mice orally exposed to scrapie exhibit widespread PrPSc accumulation 
on the surface of FDCs as well as within tingible body macrophages of secondary lymphoid follicles [13, 19, 25]. A similar 
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accumulation of PrPSc on FDCs is seen in mouse models and in humans with variant Creutzfeldt-Jakob disease (vCJD) [10, 16]. 
While Sigurdson et al. [32] did not examine lymphoid tissues of elk with CWD, similar staining characteristics reported in mule 
deer by Spraker et al. [35] and in elk by Spraker et al. [33] suggest that preferential FDC accumulation of PrPSc also takes place in 
elk.
The reason for the preferential accumulation of PrPSc on the surface of FDCs in cervids is not known although McCulloch et al. 
[26] have shown that FDC expression of PrPC is required for the accumulation of PrPSc in the spleen of mice. FDCs are stromal 
cells that play a crucial role within the germinal center as antigen presenting cells [18]. FDCs present unprocessed antigens to 
B lymphocytes via complement and/or Fc receptors and turn-off apoptosis of those B lymphocytes that meet antigen affinity 
and specificity binding requirements [21, 22]. In persistent viral diseases such as HIV-1 and bovine viral diarrhea virus (BVDV) 
infection, FDCs have been shown to trap and express antigens on their surface for extended periods (up to 1 year) [7, 15]. A similar 
antigen trapping mechanism may be responsible for the accumulation of PrPSc on the surface of FDCs in natural hosts of CWD. 
However, FDCs may simply express an increased number of PrPC on their surface, and simple in situ conversion of the isoform to 
PrPSc would also explain the preferential accumulation of PrPSc on the surface of FDCs.
In both humans and mice, FDCs have been shown to express high levels of PrPC relative to other lymphoid cell types [3, 37]. 
In the same mouse model, PrPC expression by FDCs was shown to be a requirement for lymphoid accumulation of PrPSc and 
eventual neuroinvasion [3, 4]. While these studies portray the PrPc characteristics of FDCs as important in the pathogenesis of 
other prion disease models, the PrPC association with FDCs has previously not been examined in cervids. Therefore we studied 
the PrPc distribution relative to cell phenotype markers within palatine tonsils of uninfected mule deer and elk using double 
immunofluorescent labeling and laser scanning confocal microscopy. We set out to determine if the high association of PrPSc 
with FDCs that was seen by Sigurdson et al. [32] can be explained by a high relative expression of PrPC on FDC surfaces prior 
to infection. We chose to examine palatine tonsils because the anatomic location in the oropharynx and close proximity to orally 
acquired potential antigens suggests they may serve as initial portals of entry for naturally acquired infectious prions.
MATERIALS AND METHODS
Collection of deer and elk tonsil tissues
Palatine tonsils were collected from carcass heads of hunter-killed mule deer and elk brought to the Wyoming State Veterinary 
Laboratory (WSVL) for CWD diagnostic testing. Tonsils were placed in 10% neutral buffered formalin before being processed 
and embedded in paraffin wax. Paraffin embedded blocks of tonsils from eight mule deer and eight elk that had been diagnosed as 
negative for CWD via IHC of retropharyngeal lymph node were selected for this study. The age of mule deer and elk used for this 
study ranged from approximately 1–6 years.
Formalin-fixed, paraffin embedded tonsil tissues from CWD positive mule deer and elk were archived samples from previous 
CWD research projects in the Department of Veterinary Sciences at the University of Wyoming. Prior to the initial trimming, 
these CWD positive tissues had been allowed to fix in neutral buffered formalin, immersed in 98% formic acid for 1 hr and rinsed 
extensively in running tap water before being processed and embedded in paraffin wax.
Antibodies
Primary antibodies used in this study are summarized in Table 1. To label PrPC and PrPSc, mAb F99/97.6.1 was used that is 
specific for amino acids 220–225 near the C-terminus of the mule deer and elk prion protein [29]. Validated diagnostic tests utilize 
mAb F99/97.6.1 and the staining characteristics have been preveiously described [35]. Secondary antibodies used for confocal 
microscopy were species or isotype specific and conjugated to synthetic fluorescent tags DyLight 488 or DyLight 549.
Validation of antibody reactivity to cervid tissues
Due to a lack of commercially available antibodies raised against cervid antigens, we tested potential commercial antibodies in 
both cervid tissues and the species of antigen origin to assure adequate cross reactivity to cervid tissues. For the cross validation 
Table 1. Summary of primary antibodies used in this study
Antibody Cell phenotype Specificity Isotype Source
pAb A 0452 T cells Human CD3 Rabbit immune serum DAKOd)
mAb BAQ15A B cells, FDCs Bovine CD21 IgM VMRDe)
mAb BAQ44A B cells Undefineda) IgM VMRDe)
mAb CNA.42 FDCs 120-kd FDC specific glycosylated antigen [30] IgM DAKOd)
mAb 2–137 FDCs Undefinedb) IgM A. Youngc)
mAb F99/97.6.1 N/A PrP IgG1 VMRDe)
a) Exact epitope undefined. Antibody developed using bovine PBMCs as antigen. Staining characteristic determined to specifically label a 
portion of B cells in peripheral blood by FACS profile available at www.vmrd.com. b) Exact epitope undefined. Antibody developed using 
membrane suspension of sheep ileal Peyer’s patches as antigen [7]. Specifically labels the surface and cytoplasm of cells within the GC that 
are morphologically consistent with follicular dendritic cells (FDCs). C) Antibody generously gifted by Dr. Alan Young, South Dakota State 
University. d) Dako, Glostrup, Denmark. e) VMRD, Pullman, WA, U.S.A.
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of antibodies pAb A 0452 and mAb CNA.42, human tonsils were obtained from Ivinson Memorial Hospital in Laramie, Wyoming 
from routine tonsillectomy procedures. A proposal submitted to the University of Wyoming Institutional Review Board for the use 
of human tissues was reviewed and given exempt status. All antibodies used in this study showed adequate cross reactivity as they 
were found to bind to cells with the same morphology and distribution, regardless of the species.
PrPC labelling
Because the validated diagnostic PrPSc IHC detection protocol eliminates the staining of PrPC in cervid tissues, we developed 
a tissue preparation protocol that produced optimal staining of PrPC using mAb F99. To accomplish this, we omitted the one hour 
formic acid treatment used for CWD diagnostic testing, as well as the 5 min formic acid treatment of tissue sections, and lowered 
the target retrieval solution temperature from 120°C to 93°C. This allowed for adequate epitope retrieval and binding of PrPC 
without complete denaturation of the epitope.
Immunohistochemistry
Unless otherwise noted, all staining reagents and supplies were purchased from DAKO, Glostrup, Denmark. Five micron thick 
sections of CWD-negative tissue were cut and mounted onto positively charged slides and air dried for a minimum of 12 hr. Slides 
were then deparaffinized, rehydrated and immersed in target retrieval solution for 20 min at 93°C for PrPC labeling or 120°C for 
cell phenotype markers. Slides were cooled for 10 min at room temperature, rinsed in phosphate buffered saline (PBS), incubated 
with dual endogenous enzyme blocking reagent to quench endogenous peroxidase for 5 min at room temperature, and incubated 5 
min in serum free protein block. Slides were incubated with primary antibodies for 1 hr at room temperature followed by host and 
isotype specific secondary antibodies conjugated to horse radish peroxidase (HRP) (Jackson Immunoresearch, West Grove, PA, 
U.S.A.) for an additional 20 min at room temperature. Slides were then incubated with 3,3′-Diaminobenzidine (DAB) chromogen 
solution for 10 min before counterstaining with hematoxylin and coverslipping. Negative controls consisted of either mouse isotype 
matched antibody or normal rabbit serum at equal protein concentrations.
CWD positive tissue sections were cut and deparaffinized as above. Prior to immersion in target retrieval solution for 20 min at 
120°C, slides were pretreated with 98% formic acid for 5 min and washed 3X in tris buffered saline (TBS) for 2 min. Incubation 
with primary antibody (F99 1:100 dilution) was for 10 min at room temperature to probe for PrPSc. Secondary antibody, DAB 
chromogen and counterstaining was as described above for staining PrPC and cell markers.
Immunofluorescent staining
CWD negative tissue sections were cut (5 µm) and mounted onto positively charged slides and air dried for a minimum of 12 
hr. Following deparaffinization, rehydration and immersion in target retrieval solution (20 min, 93°C, 10 min cooling), slides were 
rinsed twice in PBS and incubated with serum free protein block for 5 min. All antibody incubation steps were separated with two 
rinses in PBS and one rinse in wash buffer. Sections were first exposed to F99 (1:100 dilution) anti-PrP mAb overnight at 4°C 
followed by 60 min incubation at 37°C with a mouse IgG1 specific secondary antibody conjugated to the synthetic tag DyLight 
488 (Jackson Immunoresearch). Slides were then incubated with cell marker antibodies for 10–12 hr at 4°C followed by incubation 
with an IgM or rabbit immunoglobulin specific secondary antibody conjugated to the synthetic tag DyLight 549 (Jackson 
Immunoresearch) for 60 min at 37°C. Slides were coverslipped using Permount anti-fading medium (Fisher Healthcare, Waltham, 
MA, U.S.A.) and kept in the dark at 4°C overnight before being examined by confocal microscopy. Negative control protocols 
included either isotype matched mouse immunoglobulin or normal rabbit serum at the appropriate protein concentration.
For fluorescent labeling of PrPSc within CWD positive tissue samples, slides were prepared as described above for CWD positive 
chromogenic labeling. Primary antibody was incubated overnight at 4°C followed by secondary anti-mouse IgG1 DyLight 488 
antibody incubation for 60 min at 37°C.
Experimental treatments
To examine the degree of overlap of PrPC with the cell phenotype markers, each antibody pair treatment consisted of antibodies 
to PrPC and the respective cell marker. For each antibody pair treatment, 8 sections from each species were stained. With 5 cell 
phenotypic markers used, the result was 40 sections examined for mule deer and 40 for elk. For all 80 sections used in this study, 
images of 2 follicles were captured to be analyzed for colocalization. With two channels for each follicle, one for the 488 nm 
Argon laser that displayed PrPC staining and one for the 543 nm Helium-neon (HeNe) laser that displayed the cell phenotype 
marker staining, the study encompassed 320 lymphoid follicle images.
Confocal microscopy
A Leica TCS SP2 laser scanning confocal microscope and Argon 488 nm and HeNe 543 nm lasers were used to excite tissues 
within the respective channels sequentially and images were captured using 8-bit resolution. Two follicles were examined from 
each animal and images were captured at 200X total magnification. All images were captured using a line scanning average of 8.
Colocalization analysis
Digital data from PrPC and cell phenotype marker images were analyzed for colocalization using ImageJ software [30]. 
Colocalization was calculated using two methods. First, the Colocalisation Threshold program within ImageJ was used to obtain 
a Pearson’s correlation coefficient (Rcoloc) value for each 488 nm (PrPC) and 543 nm (cell marker) pair of images using pixels 
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of intensity equal to or greater than the threshold determined by the software. Pearson’s correlation coefficient is considered a 
standard measure of pattern recognition describing intensity distribution correlation between images. Rcoloc values range from 
−1.0 to 1.0 where −1.0 indicates complete negative correlation, 0 indicates no significant correlation and 1.0 indicates complete 
positive correlation [44]. For each antibody pair, Rcoloc values from the two follicles of each animal were averaged. These mean 
Rcoloc values were analyzed for significance using a one-way analysis of variance (ANOVA) with an alpha of 0.05 and Tukey’s 
least significant difference (LSD).
The second method of analysis also used the Colocalisation program within ImageJ and thresholds were determined as above. 
An image of above-threshold colocalized pixels was obtained and the calculated percent area of colocalized pixels was divided 
by the percent area of each respective cell marker. The result is the percent area of each cell marker image that is both above 
threshold, and colocalized with PrPC. For data analysis, a one-way ANOVA with an alpha of 0.05 and Tukey’s LSD as above was 
used to determine significant differences of percent colocaltion among the cell phenotypes.
RESULTS
B lymphocytes express PrPC
BAQ44A staining with fluorescently tagged secondary antibodies was relatively uniform throughout the tonsil with a slight 
increase in cellular density in and around the germinal centers (Fig. 1a and 1d). Both mule deer and elk tonsils displayed 
colocalization of PrPC and B lymphocytes shown as yellow pixels when PrPC and B lymphocyte images of the same field of 
view are merged (Fig. 1c and 1f). Isotype matched negative control sections exhibited no detectable staining (Fig. 1g–i). When 
all the fluorescent PrPC+B cell image pairs were analyzed, mAb BAQ44A and mAb F99 had a mean Rcoloc of 0.8161 for mule 
deer and 0.8886 for elk indicating positive colocalization in both species. Also, the average percent of mAb BAQ44A found to 
colocalize with mAb F99 was 50.95% for mule deer and 56.54% for elk. Since mAb BAQ44A labels mainly the cell surface of B 
lymphocytes, these results suggest that tonsillar B lymphocytes in deer and elk express surface PrPC (Fig. 1j–l).
PrPC expression by FDCs
To investigate the PrPC expression level of FDCs we utilized anti-FDC mAbs CNA.42 and 2–137 (Table 1). Both antibodies 
label surface and cytoplasmic epitopes of FDCs on sections of mule deer and elk (Fig. 2). Also mAb 2–137 stained a small number 
of cells outside the germinal centers that are not morphologically consistent with FDCs (Fig. 3d). Since the number of positively 
stained perifollicular non-FDC cells was very small, their contribution to results concerning colocalization was considered 
minimal. Within the follicular zone, each antibody labels cells that are morphologically typical of FDCs. Both anti-FDC antibodies 
colocalize with mAb F99 as evident by yellow pixels in merged images (Fig. 3c and 3f). When individual FDCs were viewed at 
higher magnification, colocalization was seen both on the surface as well as within the cytoplasm of FDCs (Fig. 4). Colocalization 
analysis of mAb CNA.42 resulted in mean Rcoloc values of 0.8347 for mule deer and 0.8337 for elk samples. Mean percent 
colocalization results for mAb CNA.42 were 51.00% for mule deer and 48.02% for elk. When mAb 2–137 images were analyzed, 
the mean Rcoloc and percent colocalization values were 0.9280 and 57.06% respectively for mule deer whereas elk values were 
0.9430 and 54.52% respectively. Rcoloc values and percent colocalization of the images for both anti-FDC antibodies indicate 
expression of PrPC by FDCs within palatine tonsil germinal centers of both species.
Colocalization of CD21 and PrPC
As a supplemental cell marker for B lymphocytes and FDCs, we analyzed the colocalization of PrPC with mAb BAQ15A that is 
specific for CD21 (Fig. 5). Since CD21 is expressed by both B lymphocytes and FDCs [38], BAQ15A colocalization characteristics 
could assist in validating the results mentioned above for mAbs BAQ44A, CNA.42 and 2–137. Upon image analysis, the Rcoloc 
values for BAQ15A concerning PrPC colocalization were 0.9017 and 0.9060 for mule deer and elk respectively. The BAQ15A 
percent colocalization was determined to be 35.99% for mule deer and 38.53% for elk. While the Rcoloc values for BAQ15A in 
both species (mule deer–0.9017, elk–0.9060) falls between the Rcoloc values for mAbs BAQ44A (mule deer–0.8161, elk–0.8886) 
and 2–137 (mule deer–0.9280, elk–0.9430), the percent colocalization is substantially lower than all other cell types. This result 
may be explained by CD21 expression levels being lower than expression levels of the epitopes for mAbs BAQ44A, CNA.42 and 
2–137. Another possible factor that may have influenced this result is the fact that mAb BAQ15A was raised against bovine CD21 
and may have a slightly decreased affinity for cervid CD21. While the affinity of mAb BAQ15A may have influenced our percent 
colocalization values, there is no evidence to suggest that mAb BAQ15A is not specific for cervid CD21, and thus the Rcoloc and 
percent colocalization results indicate that CD21 colocalizes with PrPC. This BAQ15A colocalization data supports our previous 
conclusions that PrPC is expressed by tonsillar B lymphocytes and FDCs.
T lymphocytes express PrPC
To label T lymphocytes we used pAb A 0452 that is specific for the human CD3 molecule on the surface of T lymphocytes. 
PAb A 0452 staining labeled many cells lining the outside of the germinal center in the “T cell zone” with follicular T cells 
lightly dispersed within the germinal center. The general location of positively stained cells in and around the germinal center was 
consistent with human tonsil sections chromogenically stained, with an apparent slight decrease in affinity for the cervid CD3. 
The fluorescent signal from pAb A 0452 staining originated from on or very near the cell surface of T lymphocytes (Fig. 6). On 
sections examined for both mule deer and elk, pAb A 0452 colocalized with PrPC in merged images (Fig. 7c and 7f). The majority 
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of colocalization for pAb A 0452 and PrPC occured outside the germinal center within the “T cell zone”. The number of follicular 
T cells varied greatly within follicles of each species. Mean Rcoloc values for pAb A 0452 colocalization were 0.8974 and 0.8776 
for mule deer and elk respectively. The percent colocalization of pAb A 0452 was 48.75% for mule deer while the elk images had 
a 59.05% colocalization. We interpret these results as indicating expression of PrPC on the surface of CD3+ T lymphocytes. Rcoloc 
Fig. 1. BAQ44A (red) and PrPC (green) images in the same field of view of mule deer (panels a, b) and elk (panels d, e) tonsils colocalized 
as yellow in merged images (panels c, f). Isotype matched negative controls (panels g–i). Bars, 80 µm. High magnification images showing 
surface colocalization of mAb BAQ44A and PrPC (panels j–l). Bars 1 µm. Dashed line represents approximate germinal center borders.
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and percent colocalization data means for all antibody pair treatments used in this study are summarized in Table 2.
Comparing the PrP distribution in tonsils of CWD positive and CWD negative animals
Using our developed PrPC tissue preparation protocol and the normal diagnostic PrPSc detection protocol, we investigated the 
anatomical distribution of PrPC and PrPSc within tonsils of CWD infected and uninfected mule deer and elk. Tonsils stained from 
infected mule deer exhibited a characteristic intense IHC staining of PrPSc within the germinal centers of secondary follicles 
(Fig. 8a). However, the PrPC distribution within tonsils of uninfected mule deer appeared as widespread staining not defined by 
the apparent boundaries of the germinal centers (Fig. 8b). The same differential staining characteristics were seen when PrP of 
both isoforms was labeled with immunofluorescent secondary antibodies (Fig. 9). The same distributions were seen for PrPC 
and PrPSc in tonsils of CWD negative and positive elk labeled for IHC and with immunofluorescent antibodies (data not shown). 
The PrPSc staining confined to the germinal centers of CWD positive mule deer and elk seen here can be attributed to the surface 
Fig. 2. Fluorescent images of follicular dendritic cells. (a) Mule deer section stained using mAb CNA.42. (b) Mule deer section stained using 
mAb 2-137. Note characteristic dendritic processes as well as surface and cytoplasmic staining. Sections of elk tonsil displayed the same 
staining characteristics (data not shown). Bars, 2 µm. White dashed lines outline the cellular surface.
Fig. 3. Sections of elk tonsil. PrPC (green) colocalization with follicular dendritic cel markers (red) using mAb CNA.42 (top row) and mAb 
2-137 (bottom row). Note the oval outline of the central follicular zone in the lower magnification images of panels d–f. Bars, 15 µm (panels 
a–c), 40 µm (panels d–f). Dashed line represents approximate germinal center borders.
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Fig. 4. Elk tonsil. Colocalization of PrPc (green) with mAb 2–137 (red). Bars, 1 µm. White arrow highlighting surface colocalization. Black 
star highlighting intracytoplasmic colocalization.
Fig. 5. Sections stained for CD21 (red) and PrPC (green). Colocalization is seen both within the follicular dendritic cell (FDC) network and 
outside the follicle on B lymphocytes (panels a, b, and f). Image showing the colocalization of CD21 and PrPC within the cytoplasm of a 
FDC (panels d–f). Bars, 50 µm (panels a–c), 1.5 µm (panels d–f). Dashed line represents approximate germinal center borders.
Fig. 6. T lymphocytes stained with mAb A 0452 on sections of elk (a) and mule deer (b). Bars, 1.5 µm.
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accumulation by FDCs and B lymphocytes as described by Sigurdson et al. [32]. Also, the widespread distribution of PrPC 
supplements the data described here concerning the colocalization of PrPC and cell markers by staining within the FDC network 
and also staining outside the germinal center in areas including the “T cell zone”.
DISCUSSION
Here we have demonstrated the distribution of PrPC among three major cell phenotypes in lymphoid follicles of two naturally 
occurring hosts of CWD. We used double immunolabeling and laser scanning confocal microscopy to show that PrPC is expressed 
by B and T lymphocytes as well as FDCs in mule deer and elk tonsils. While these three cell phenotypes express PrPC, other cells 
within lymphoid follicles, namely macrophages and mobile dendritic cells were not examined and might also express PrPC.
The only statistical difference in Rcoloc values of elk were those of mAbs 2–137 and CNA.42 which both label FDCs. Mule 
deer had an Rcoloc difference between mAbs 2–137 and CNA.42 as well as BAQ44A. The other cell markers’ Rcoloc values were 
the same statistically both to each other, and to each of the anti-FDC mAbs. Since each anti-FDC antibody clearly labeled FDCs, 
this result could be due to a difference in the level of expression of their respective epitopes by FDCs. Having a high correlation 
value exist between cell markers for B lymphocytes and FDCs with PrPC is in agreement with the distribution seen among these 
cell types concerning their association with PrPSc in infected animals [32]. An interesting result of this study was the relatively high 
Rcoloc values for CD3 and PrPC on T lymphocytes of both species. The expression of PrPC by T lymphocytes has been previously 
described in humans, goats, and mice [5, 12, 17, 20, 23] but not yet in cervids as far as the authors are aware. This is in contrast 
Fig. 7. PrPC (green) colocalization with CD3 (red) on tonsil sections from mule deer (top row) and elk (bottom row). Negative control sections 
exhibited no detectable staining (data not shown). Bars, 50 µm. Dashed line represents approximate germinal center borders.
Table 2. Rcoloc and percent colocalization with mAb F99 means for all antibody pair treatments used in this study (n=8)
Antibody
Rcoloc Rcoloc % Colocalization % Colocalization
(Mule deer) (Elk)  (Mule deer) (Elk)
mAb BAQ44A (B lymphocytes) 0.8161 0.8886 50.95 56.54
mAb BAQ15A (B lymphocytes & FDCs) 0.9016 0.9060 35.99 38.53
pAb A 0452 (T lymphocytes) 0.8974 0.8776 48.75 59.05
mAb CNA.42 (FDCs)a) 0.8347 0.8337 51.00 48.02
mAb 2-137 (FDCs) 0.9280 0.9430 57.06 54.52
a) FDCs, follicular dendritic cells.
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to the very low level of PrPSc seen in association with T lymphocytes in CWD infected animals [32]. This result could explain 
the apparent difference in distribution of PrPC since the more widespread distribution of PrPC on uninfected tissues occurs where 
a large portion of T lymphocytes are present (Figs. 8 and 9). This implies that the accumulation of PrPSc is not solely due to the 
presence of PrPC and that there is a pathological characteristic of CWD that promotes the preferential accumulation of PrPSc on the 
surfaces of FDCs and B lymphocytes, but not T lymphocytes.
The only difference in percent colocalization seen among the phenotypic markers for this study for both mule deer and elk is 
that of mAb BAQ15A (Table 2). Since CD21 is expressed by both B lymphocytes and FDCs [38], one would expect the percent 
colocalization of BAQ15A with PrPC to be much closer to the percent colocalization of cell marker mAbs BAQ44A, CNA.42 
and 2–137. Yet as suggested above, mAb BAQ15A may have lower cross reactivity to cervid antigens compared to that of mAbs 
BAQ44A, CNA.42 and 2–137. While percent colocalization provides supplemental data to support the expression of PrPC in addition 
to Rcoloc values, percent colocalization cannot be used to determine the percentage of cells that express the protein of interest. This 
is because the cell phenotypic markers used for each cell type may be expressed at variable rates among the cell types.
When comparing the percent colocalization data for this study to that of PrPSc determined by Sigurdson et al. [32] several 
differences are apparent. First is the increase in colocalization of mAb CNA.42 with PrPC. Since CNA.42 exhibited extensive 
intracellular labeling, its colocalization with PrPC suggests that FDCs actively produce PrPC intracellularly. Perhaps the most 
intriguing result of this study however is the percent colocalization of CD3 and PrPC seen in mule deer (48.75%) and elk (59.05%) 
compared to virtually no colocalization between the same in CWD infected animals with respect to PrPSc.
These differences with respect to T lymphocyte PrPC vs PrPSc characteristics would appear to support the results of Davenport et 
al. [6] that determined PrPC expression levels was not the sole driver of PrPSc accumulation. It may be that T lymphocytes are not 
involved in PrPSc propagation and they merely express PrPC prior to infection. They may not be susceptible to isoform conversion 
or are potentially not directly exposed to PrPSc during infection.
Fig. 8. Immunohistochemistry staining for PrP in palatine tonsils of mule deer. (a) Tonsil follicle stained for PrPSc in a chronic wasting disease 
(CWD) positive mule deer. (b) Tonsil follicle of CWD negative mule deer stained for PrPC. Note that the staining of PrPC appears much 
more widespread and substantial amounts of PrPC appear outside the central follicular zone (arrows). Bars a) 35 µm, b) 70 µm. Dashed line 
represents approximate germinal center borders.
Fig. 9. Confocal images of PrP stained tonsil follicles in mule deer. (a) Tonsil follicle stained for PrPSc from a CWD positive mule deer. 
Notice staining is confined largely to the germinal center. (b) Tonsil follicle stained for PrPC from a CWD negative mule deer. Note much 
more dispersed staining outside the germinal center when compared to panel (a). Figure 9b is identical to Fig. 1b. Bars, 70 µm. Dashed line 
represents approximate germinal center borders.
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This study provides data previously unknown for the expression levels of PrPC in natural hosts of CWD. The most common 
cell type implicated in prion disease lymphoid pathogenesis research seems to be the FDC [1, 3, 4, 8, 9, 11, 15, 18, 25, 31], and 
our results support that by showing FDC expression of PrPC in natural hosts for CWD. Future work that examines the distribution 
of PrPC utilizing anti-PrP antibodies with epitopes distinct from mAb F99/97.6.1 may be beneficial to determine if the protein is 
expressed in the same fashion across the cell types. Any differences in the expression characteristics may shed light on potential 
isoform conversion resistance mechanisms among the cell types.
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